The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr.V.G. Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.
Here are the latest updates:
Fatality rate in Kalyana Karnataka is lower than State, national average
Even though Kalyana Karnataka region opened India’s COVID-19 fatality account by reporting the country’s first death from one of its cities — Kalaburagi — in the second week of March this year, the region continues to maintain lower death rate as compared to State and national average.
An analysis of COVID-19 data showed that the region recorded a 1.48 % death rate as against the national average of 2.1 % and the State average of 1.86 % as on July 31, 2020.
9.30 am | Karnataka
NGOs join hands with the govt. in the fight against pandemic
Volunteers from Anjuman-e-Islam preparing oxygen cylinders to be distributed free to COVID-19 patients in Belagavi.
Some non-governmental organisations (NGOs) are helping poor patients battle COVID-19 by providing them free oxygen cylinders.
The Anjuman-e-Islam committee in Belagavi has tied up with industrial gas industries and plans to provide oxygen cylinders to the needy. The committee will provide 120 cylinders in the first phase. It plans to increase the numbers in the next few weeks.
Assam unlocks as COVID-19 positivity rate declines
The Assam government on Sunday announced a slew of lockdown relaxations but as an experiment for 12 days in view of the decline in the COVID-19 positivity rate. This follows the decision on reopening schools and colleges from September 1 if the situation improves and the Centre gives the go-ahead.
8.30 am | Tamil Nadu
Callers offer BCG vaccine to elderly without mentioning trial
Disinfectant sprayed on buildings in Raja Street, Coimbatore on Sunday during the complete lockdown to check the spread of COVID-19
| Photo Credit:
S. SIVA SARAVANAN
In the ongoing BCG vaccine trial, a few elderly residents of Chennai have been receiving calls from persons representing the Indian Council of Medical Research (ICMR), offering the vaccine as a “protection” and “immunity booster”. But these residents, who had tested negative for COVID-19, are not being appropriately informed that this is a “trial”.
BCCI advises individuals over 60 to stay away from cricket training
The Board of Control for Cricket in India (BCCI) has advised coaches and support staff members above 60 years of age to be discouraged from participating in training. The suggestion is included in the standard operating procedures (SOPs) for resumption of domestic cricket, which were shared with all the 38 affiliate units of the BCCI on Sunday.
7.30 am | Tamil Nadu
CM warns of action against overcharging pvt. hospitals
A day after the Health Department suspended the recognition of Be Well Hospitals in Kilpauk, Chennai, as a COVID-19 facility after it overcharged a patient, Chief Minister Edappadi K. Palaniswami has warned of strict action against private hospitals charging in excess.
In a tweet on Sunday, Mr. Palaniswami said that all private hospitals treating COVID-19 patients should display government-recognised treatment costs for the benefit of the people.